25.07.2014 • NewsDede WillamsMerckMerck Serono

Merck Serono Extends Italian Alliance for Neurodegenerative Diseases

Merck Serono, the biopharmaceuticals arm of Germany's Merck KgaA, is extending by two years its 10-year R&D cooperation with San Raffaele University & Research Hospital for Research in Milan focusing on neurodegenerative diseases.

The partners are aiming at the development of pre-clinical and clinical research projects with a focus on developing innovative therapies against serious and disabling neurological diseases such as multiple sclerosis affecting young adults in particular.

San Raffaele University & Research Hospital are providing know-how and laboratories to develop new therapies and to evaluate the effectiveness of the molecules developed by Merck Serono.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.